| Detected | Trial | Change |
|---|---|---|
| 2026-08-13 | NCT06725550 Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0 |
Enrollment reopened |
| 2026-08-13 | NCT06725550 Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0 |
Enrollment increased: 10 -> 120 participants |
| 2026-08-13 | NCT06725550 Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0 |
Sponsor changed: Indiana University -> University of Cincinnati |
| 2026-08-13 | NCT06725550 Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0 |
date change Primary completion pushed: 2026-04-02 -> 2030-06-28 |
| 2026-08-13 | NCT06725550 Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0 |
date change Completion pushed: 2027-04-02 -> 2031-06-28 |
| 2026-08-12 | NCT04594772 Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic… |
date change Completion pushed: 2026-06-01 -> 2027-06-01 |
| 2026-08-04 | NCT06795451 Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential… |
date change Primary completion pushed: 2026-07-31 -> 2027-03-31 |
| 2026-08-04 | NCT06795451 Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential… |
date change Completion pushed: 2026-07-31 -> 2027-03-31 |
| 2026-08-02 | NCT06679426 Safety and Efficacy of Conestat Alfa for ACE-Induced Angioedema |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-01 | NCT06725550 Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0 |
Enrollment closed, study ongoing |
| 2026-08-01 | NCT06725550 Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0 |
Enrollment reduced: 120 -> 10 participants |
| 2026-08-01 | NCT06725550 Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0 |
date change Primary completion moved earlier: 2029-08-31 -> 2026-04-02 |
| 2026-08-01 | NCT06725550 Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0 |
date change Completion moved earlier: 2030-08-30 -> 2027-04-02 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT04245436 | Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A) | Anxiety | Recruiting |
| NCT04245748 | Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD) | Anxious Depression | Recruiting |
| NCT04623099 | Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to… | Anxiety | Recruiting |
| NCT04221997 | Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or… | Anxiety Disorders | Recruiting |
| NCT06574022 | Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative… | Mastectomy; Lymphedema | Recruiting |
| Phase 3 | |||
| NCT07464886 | Prefrontal Glutamatergic Modulation by NAC and MBCT for Depression in Youth | Mild Depression | Recruiting |
| NCT03150914 | Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial | LAM | Active, Not Recruiting |
| NCT05115331 | Palliative UNConventional Hypofractionation Trial for Metastatic Bone Disease | Metastatic Bone Tumor | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT05902533 | REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation | Anal Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT05337618 | Improving Neurotrauma by Depolarization Inhibition With Combination Therapy (INDICT) | Traumatic Brain Injury | Recruiting |
| NCT06416007 | Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors | Cancer | Recruiting |
| NCT04594772 | Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic… | Pancreas Cancer | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT05560477 | Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing | Meniscus Tear | Recruiting |
| NCT07213934 | Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation… | Head and Neck Cancer | Recruiting |
| NCT06795451 | Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential… | Depression - Major Depressive Disorder | Recruiting |
| NCT04340258 | Trial Combining Pembrolizumab and Cesium 131 Brachytherapy With Salvage Surgery in HNSCC | HNSCC | Active, Not Recruiting |
| Phase 1 | |||
| NCT05605366 | Minocycline In Neurocognitive Outcomes - Sickle Cell Disease | Sickle Cell Disease | Not Yet Recruiting |
| Early Phase 1 | |||
| NCT07231588 | Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation | Radiation Injuries | Recruiting |
| NCT06470295 | Effect of C-peptide on Hypoglycemic Counterregulation | Hypoglycemia | Recruiting |
| NCT06163482 | Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis | Cystic Fibrosis | Recruiting |
| NCT03122197 | Study of Letrozole in Recurrent Gliomas | Brain Tumor | Recruiting |
| Not specified | |||
| NCT03187925 | Cricopharyngeal Dysfunction and Esophageal Diverticulum | Zenker Diverticulum | Recruiting |
| NCT05973799 | Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes | Hypoglycemia | Recruiting |
| NCT06727097 | Post-Stroke Sensory Reweighting on Walking and Balance Outcomes | Ischemic Stroke | Recruiting |
| NCT02432560 | Safety and Durability of Sirolimus for Treatment of LAM | Lymphangioleiomyomatosis | Recruiting |